Determination of Nitrosamines

Home - R&D Studies - Determination of Nitrosamines

Accredited to ISO 17025 standards, WMINOLAB operates as a trusted global partner in the Determination of Nitrosamines, Method Validation, and Risk Assessment services, leveraging its team of experts and state-of-the-art instrumentation

Determination of Nitrosamines

Nitrosamines are chemical compounds, generally containing the chemical structure N-N=O, and are classified as possible human carcinogens. Since these compounds damage DNA, they can be classified as genotoxic impurities

In July 2018, the European Medicines Agency (EMA) issued a safety alert regarding the detection of the carcinogenic impurity N-nitrosodimethylamine (NDMA) in products containing the active ingredient valsartan

Due to the fact that nitrosamines can form not only during the production process of some raw materials, but also in the presence of some solvents, agents and raw materials and carry a risk of contamination, it is requested that risk assessment studies be carried out by the authorities for all products

WMINOLAB creates a study plan based on the acceptable daily intake amounts defined by USFDA and EMA, taking into account the daily intake doses.

We develop and validate product-specific methods in accordance with ICH Q9 Quality Risk Management to provide efficient solutions for the detection of nitrosamines, which are particularly challenging to identify in pharmaceutical formulations due to matrix effects

Determination of Nitrosamines

Nitrosamine Impurities

NITROSAMINE RISK ASSESSMENT FOR FINISHED PRODUCTS AND RAW MATERIALS

Determination of Nitrosamines

Personnel

Determination of Nitrosamines

Equipment

Determination of Nitrosamines

Material

Determination of Nitrosamines

Process

Determination of Nitrosamines

Production

Nitrosamine Impurities

Study Plan of Nitrosamine Impurities

Nitrosamine Impurities Work Plan

Through Nitrosamine Determination, we offer: